CXCR4 and Sepsis: Another study showed that pharmacologic antagonism of CXCR4 with plerixafor improved the survival of mouse with polymicrobial sepsis and reduced sepsis-induced peripheral T cell loss, highlighting the crucial role of CXCR4 in controlling sepsis-induced immune dysfunction and mortality [13].